Abbott Laboratories (ABTT34)
Market Closed
16 Jun, 19:55
B3 B3 Primary R$
63. 30
+0.24
+0.38%
R$
- Market Cap
36.49 P/E Ratio
2.2% Div Yield
78 Volume
4.44 Eps
R$ 63.06
Previous Close Day Range
63.3 63.3
Year Range
45.81 67.65
Earnings results expected in 27 days
Summary
ABTT34 closed Monday higher at R$63.3, an increase of 0.38% from Friday's close, completing a monthly decrease of -0.66% or R$0.42. Over the past 12 months, ABTT34 stock gained 9.33%.
ABTT34 pays dividends to its shareholders, with the most recent payment made on May 21, 2025.
The last earnings report, released on Apr 16, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jul 16, 2025.
Abbott Laboratories has completed 1 stock splits, with the recent split occurring on Nov 21, 2022.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on B3 (BRL).
Want to track ABTT34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ABTT34 Chart
Loading, please wait...
Abbott Laboratories Dividends
| ABTT34 In 3 weeks Estimated | Other | R$0.19 Per Share |
| ABTT34 2 months ago Paid | Other | R$0.19 Per Share |
| ABTT34 5 months ago Paid | Other | R$0.19 Per Share |
| ABTT34 8 months ago Paid | Other | R$0.18 Per Share |
| ABTT34 11 months ago Paid | Other | R$0.5 Per Share |
| ABTT34 11 Apr 2024 Paid | Other | R$0.16 Per Share |
Abbott Laboratories Earnings
| 16 Jul 2025 (27 Days) Date | | - Cons. EPS | - EPS |
| 16 Apr 2025 Date | | - Cons. EPS | - EPS |
| ABTT34 In 3 weeks Estimated | Other | R$0.19 Per Share |
| ABTT34 2 months ago Paid | Other | R$0.19 Per Share |
| ABTT34 5 months ago Paid | Other | R$0.19 Per Share |
| ABTT34 8 months ago Paid | Other | R$0.18 Per Share |
| ABTT34 11 months ago Paid | Other | R$0.5 Per Share |
| ABTT34 11 Apr 2024 Paid | Other | R$0.16 Per Share |
| 16 Jul 2025 (27 Days) Date | | - Cons. EPS | - EPS |
| 16 Apr 2025 Date | | - Cons. EPS | - EPS |
Abbott Laboratories (ABTT34) FAQ
What is the stock price today?
The current price is R$63.30.
On which exchange is it traded?
Abbott Laboratories is listed on B3.
What is its stock symbol?
The ticker symbol is ABTT34.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
What is the earnings per share?
The EPS is 0.
When is the next earnings date?
The next earnings report will release on Jul 16, 2025.
Has Abbott Laboratories ever had a stock split?
Abbott Laboratories had 1 splits and the recent split was on Nov 21, 2022.
Abbott Laboratories Profile
| Medical - Devices Industry | Healthcare Sector | Mr. Robert B. Ford CEO | B3 Exchange | - ISIN |
| US Country | 114,000 Employees | 11 Apr 2025 Last Dividend | 21 Nov 2022 Last Split | 13 Jan 1978 IPO Date |
Overview
Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.
Products and Services
Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:
- Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
- Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
- Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
- Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.
Contact Information
Address: 100 Abbott Park Road
Phone: 224 667 6100
Website: https://www.abbott.com
2025 © Marketlog. All Rights Reserved.
